Search research articles
Contact Us
Filters
Showing results (11-20 of 159) with videos related to
Page
of 16
Sort By:
European Heart Journal
|
August 8, 2022
Serum uric acid lowering with empagliflozin in heart failure with reduced ejection fraction: a sweet added benefit?
Isla S Mackenzie, Thomas M MacDonald
Pharmacoepidemiology and Drug Safety
|
May 25, 2007
Channelling of SSRIs and SNRIs use in the Tayside population, Scotland
Li Wei, Ruoling Chen, Thomas M MacDonald
British Journal of Clinical Pharmacology
|
May 22, 2008
Adherence to statin or aspirin or both in patients with established cardiovascular disease: exploring healthy behaviour vs. drug effects and 10-year follow-up of outcome
Li Wei, Tom Fahey, Thomas M MacDonald
Drug Safety
|
August 24, 2018
Ibuprofen and Paracetamol: Acceptably Safe for All?
Filippo Pigazzani, Isla Mackenzie, Thomas M MacDonald
European Journal of Clinical Pharmacology
|
June 27, 2012
Cardiovascular safety of lumiracoxib: a meta-analysis of randomised controlled trials in patients with osteoarthritis
Isla S Mackenzie, Li Wei, Thomas M Macdonald
BMJ (Clinical Research Ed.)
|
September 14, 2011
Co-prescription of co-trimoxazole and spironolactone in elderly patients
Li Wei, Thomas M MacDonald, Isla S Mackenzie
Arthritis Research & Therapy
|
November 26, 2008
Nitric oxide and cardiovascular effects: new insights in the role of nitric oxide for the management of osteoarthritis
Isla S Mackenzie, Daniel Rutherford, Thomas M MacDonald
Cardiovascular Therapeutics
|
July 17, 2009
Valsartan improves endothelial dysfunction in hypertension: a randomized, double-blind study
Nikolaos Tzemos, Pitt O Lim, Thomas M MacDonald
Kidney International
|
January 2, 2014
The authors reply
Li Wei, Thomas M MacDonald, Michael J Murphy
Annals of Internal Medicine
|
November 17, 2004
Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease
Li Wei, Thomas M MacDonald, Brian R Walker
Page
of 16
Search research articles
Search
Showing results (11-20 of 159) with videos related to
Sort By:
Page
of 16
European Heart Journal
|
August 8, 2022
Serum uric acid lowering with empagliflozin in heart failure with reduced ejection fraction: a sweet added benefit?
Isla S Mackenzie, Thomas M MacDonald
Pharmacoepidemiology and Drug Safety
|
May 25, 2007
Channelling of SSRIs and SNRIs use in the Tayside population, Scotland
Li Wei, Ruoling Chen, Thomas M MacDonald
British Journal of Clinical Pharmacology
|
May 22, 2008
Adherence to statin or aspirin or both in patients with established cardiovascular disease: exploring healthy behaviour vs. drug effects and 10-year follow-up of outcome
Li Wei, Tom Fahey, Thomas M MacDonald
Drug Safety
|
August 24, 2018
Ibuprofen and Paracetamol: Acceptably Safe for All?
Filippo Pigazzani, Isla Mackenzie, Thomas M MacDonald
European Journal of Clinical Pharmacology
|
June 27, 2012
Cardiovascular safety of lumiracoxib: a meta-analysis of randomised controlled trials in patients with osteoarthritis
Isla S Mackenzie, Li Wei, Thomas M Macdonald
BMJ (Clinical Research Ed.)
|
September 14, 2011
Co-prescription of co-trimoxazole and spironolactone in elderly patients
Li Wei, Thomas M MacDonald, Isla S Mackenzie
Arthritis Research & Therapy
|
November 26, 2008
Nitric oxide and cardiovascular effects: new insights in the role of nitric oxide for the management of osteoarthritis
Isla S Mackenzie, Daniel Rutherford, Thomas M MacDonald
Cardiovascular Therapeutics
|
July 17, 2009
Valsartan improves endothelial dysfunction in hypertension: a randomized, double-blind study
Nikolaos Tzemos, Pitt O Lim, Thomas M MacDonald
Kidney International
|
January 2, 2014
The authors reply
Li Wei, Thomas M MacDonald, Michael J Murphy
Annals of Internal Medicine
|
November 17, 2004
Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease
Li Wei, Thomas M MacDonald, Brian R Walker
Page
of 16